These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 30400270

  • 1. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells.
    Heyza JR, Arora S, Zhang H, Conner KL, Lei W, Floyd AM, Deshmukh RR, Sarver J, Trabbic CJ, Erhardt P, Chan TH, Dou QP, Patrick SM.
    Nutrients; 2018 Nov 03; 10(11):. PubMed ID: 30400270
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
    McNeil EM, Astell KR, Ritchie AM, Shave S, Houston DR, Bakrania P, Jones HM, Khurana P, Wallace C, Chapman T, Wear MA, Walkinshaw MD, Saxty B, Melton DW.
    DNA Repair (Amst); 2015 Jul 03; 31():19-28. PubMed ID: 25956741
    [Abstract] [Full Text] [Related]

  • 3. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.
    Arora S, Heyza J, Zhang H, Kalman-Maltese V, Tillison K, Floyd AM, Chalfin EM, Bepler G, Patrick SM.
    Oncotarget; 2016 Nov 15; 7(46):75104-75117. PubMed ID: 27650543
    [Abstract] [Full Text] [Related]

  • 4. Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP cell line through candidate genes demethylation.
    Zhang Y, Wang X, Han L, Zhou Y, Sun S.
    Biomed Pharmacother; 2015 Feb 15; 69():285-90. PubMed ID: 25661371
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
    Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick SM.
    DNA Repair (Amst); 2010 Jul 01; 9(7):745-53. PubMed ID: 20418188
    [Abstract] [Full Text] [Related]

  • 6. Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy.
    Feldmann DP, Heyza J, Zimmermann CM, Patrick SM, Merkel OM.
    Molecules; 2020 Apr 24; 25(8):. PubMed ID: 32344513
    [Abstract] [Full Text] [Related]

  • 7. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
    Kirschner K, Melton DW.
    Anticancer Res; 2010 Sep 24; 30(9):3223-32. PubMed ID: 20944091
    [Abstract] [Full Text] [Related]

  • 8. Computer-aided drug design of small molecule inhibitors of the ERCC1-XPF protein-protein interaction.
    Gentile F, Elmenoufy AH, Ciniero G, Jay D, Karimi-Busheri F, Barakat KH, Weinfeld M, West FG, Tuszynski JA.
    Chem Biol Drug Des; 2020 Apr 24; 95(4):460-471. PubMed ID: 31891209
    [Abstract] [Full Text] [Related]

  • 9. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
    Singh M, Bhatnagar P, Mishra S, Kumar P, Shukla Y, Gupta KC.
    Int J Nanomedicine; 2015 Apr 24; 10():6789-809. PubMed ID: 26586942
    [Abstract] [Full Text] [Related]

  • 10. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
    Lan L, Hayashi T, Rabeya RM, Nakajima S, Kanno Si, Takao M, Matsunaga T, Yoshino M, Ichikawa M, Riele Ht, Tsuchiya S, Tanaka K, Yasui A.
    DNA Repair (Amst); 2004 Feb 03; 3(2):135-43. PubMed ID: 14706347
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
    Kudo K, Gavin E, Das S, Amable L, Shevde LA, Reed E.
    Oncogene; 2012 Nov 01; 31(44):4718-24. PubMed ID: 22266871
    [Abstract] [Full Text] [Related]

  • 12. Computational Characterization of Small Molecules Binding to the Human XPF Active Site and Virtual Screening to Identify Potential New DNA Repair Inhibitors Targeting the ERCC1-XPF Endonuclease.
    Gentile F, Barakat KH, Tuszynski JA.
    Int J Mol Sci; 2018 Apr 30; 19(5):. PubMed ID: 29710850
    [Abstract] [Full Text] [Related]

  • 13. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
    Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH, Wong YC.
    Nutr Cancer; 2008 Apr 30; 60(4):483-91. PubMed ID: 18584482
    [Abstract] [Full Text] [Related]

  • 14. DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.
    McNeil EM, Melton DW.
    Nucleic Acids Res; 2012 Nov 01; 40(20):9990-10004. PubMed ID: 22941649
    [Abstract] [Full Text] [Related]

  • 15. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

  • 16. Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer.
    Li C, Li T, Huang L, Yang M, Zhu G.
    Chem Asian J; 2019 May 02; 14(9):1570-1576. PubMed ID: 30843348
    [Abstract] [Full Text] [Related]

  • 17. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
    Lehmann J, Seebode C, Smolorz S, Schubert S, Emmert S.
    Cell Mol Life Sci; 2017 Jun 02; 74(11):2081-2094. PubMed ID: 28130555
    [Abstract] [Full Text] [Related]

  • 18. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
    Ahmad A, Enzlin JH, Bhagwat NR, Wijgers N, Raams A, Appledoorn E, Theil AF, J Hoeijmakers JH, Vermeulen W, J Jaspers NG, Schärer OD, Niedernhofer LJ.
    PLoS Genet; 2010 Mar 05; 6(3):e1000871. PubMed ID: 20221251
    [Abstract] [Full Text] [Related]

  • 19. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
    Bergstralh DT, Sekelsky J.
    Trends Genet; 2008 Feb 05; 24(2):70-6. PubMed ID: 18192062
    [Abstract] [Full Text] [Related]

  • 20. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ, Cummings M, Köberle B, Hartley JA, Oliver RT, Masters JR.
    J Cell Biochem; 2006 Apr 01; 97(5):1121-36. PubMed ID: 16315315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.